HomeBUSINESS
BUSINESS

Eisai, Merck to Start Lenvima Commercial Collaboration in Major Markets by March-End
(Nov.2.2018)

Eisai CEO Haruo Naito
Eisai CEO Haruo Naito said on November 1 that the company and US Merck will begin rolling out their commercial arrangements on the cancer drug Lenvima (lenvatinib) in major markets by the end of FY2018 under their strategic partnership pact inked early this year ...
(LOG IN FOR FULL STORY)